✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Fredun Pharmaceuticals Ltd.

FREDUN

Market Cap
₹327 Cr.
P/E
17.41

Fredun Pharmaceuticals Ltd.

  • Fredun Pharma
  • Trident Lifeline
  • Balaxi Pharma.
  • TJI Pharma - Small Cap
FAQs on Fredun Pharmaceuticals Ltd. Shareprice

Fredun Pharma has given lower returns compared to its competitors.
Fredun Pharma has grown at ~-16.13% over the last 2yrs while peers have grown at a median rate of 26.76%

Fredun Pharma is not expensive.
Latest PE of Fredun Pharma is 17.67, while 3 year average PE is 51.0.
Also latest EV/EBITDA of Fredun Pharma is 9.6 while 3yr average is 19.2.

View FAQ's On Business
Growth Table
  • Fredun Pharmaceuticals Ltd.
  • Trident Lifeline
  • Balaxi Pharma.
Balance Sheet
  • Fredun Pharmaceuticals Ltd.
  • Trident Lifeline
  • Balaxi Pharma.
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Fredun Pharmaceuticals Ltd.
  • Trident Lifeline
  • Balaxi Pharma.
Cash Flow
  • Fredun Pharmaceuticals Ltd.
  • Trident Lifeline
  • Balaxi Pharma.
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Fredun Pharmaceuticals Ltd.
  • Trident Lifeline
  • Balaxi Pharma.
Quarterly Results
  • Fredun Pharmaceuticals Ltd.
  • Trident Lifeline
  • Balaxi Pharma.
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Fredun Pharmaceuticals Ltd. Financials

Balance sheet of Fredun Pharma is strong.
But short term working capital might become an issue for this company.

Yes, The debt of Fredun Pharma is increasing.
Latest debt of Fredun Pharma is ₹137 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹103 Crs.

Yes, profit is increasing.
The profit of Fredun Pharma is ₹18.8 Crs for TTM, ₹15.62 Crs for Mar 2024 and ₹10.81 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Fredun Pharma latest dividend payout ratio is 2.11% and 3yr average dividend payout ratio is 3.31%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech